The effect of exogenous leptin on insulin's actions and metabolic outputs has been studied mainly in leptin-deficient patients, as well as in models of experimental diabetes or obesity [11], [16]. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.